WARSAW — Zimmer Biomet Holdings Inc. announced certain of its stockholders, consisting of affiliates of KKR and TPG, intend to offer for sale in an underwritten secondary offering 7,440,675 shares of the common stock of Zimmer Biomet Holdings Inc.  The selling stockholders will receive all of the proceeds of the offering. Neither Zimmer Biomet nor any of its directors, officers or other stockholders is offering shares of common stock in the offering.

As part of the offering, Zimmer Biomet, its chief executive officer and chief financial officer and certain of its directors affiliated with KKR and TPG, will enter into lock-up agreements with respect to the sale of shares of common stock ofZimmer Biomet for a 30-day period following the offering, subject to customary exceptions.

Goldman, Sachs and Co. and JP Morgan are acting as joint book-running managers and the underwriters for the offering.

Zimmer Biomet has filed a registration statement with the U.S. Securities and Exchange Commission for the offering to which this communication relates. Before investing, it is advisable to read the preliminary prospectus supplement and final prospectus supplement when available and the accompanying base prospectus in that registration statement and other documents Zimmer Biomet has filed with the SEC for more complete information about Zimmer Biomet and this offering. These documents are available for free at www.sec.gov.